GSK vs REYN · P/E 13, $103.31B cap vs P/E 15, rev $3.72B
GlaxoSmithKline PLC ADR (GSK) versus Reynolds Consumer Products Inc (REYN) — a side-by-side from cached financials, not a winner call.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Reynolds Consumer Products Inc (REYN) is a packaging & containers company listed on NASDAQ.
GSK does not have a complete income-statement cache yet.
Latest reported REYN revenue for 2025-12-31 was $3.72B. Net income was $301.0M. Revenue was up 0.7% from 2024-12-31 to 2025-12-31. REYN currently screens at market cap $4.92B and trailing P/E 15.0.
GSK currently screens at market cap $103.31B and trailing P/E 13.5. REYN currently screens at market cap $4.92B and trailing P/E 15.0.
Not investment advice. Open the GSK and REYN stock pages for the full models.
Not investment advice.